Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature

Pediatric Blood and Cancer

Volumn 62, Issue 9, 2015, Pages 1501-1511

  Brandow, Amanda M ^a,b   Farley, Rebecca A ^a   Panepinto, Julie A ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Children's Hospital of Wisconsin   (United States)

Author keywords

Neurobiology; Neuropathic pain; Pain; Sickle cell disease

Indexed keywords

GABAPENTIN; TRIFLUOPERAZINE;

CENTRAL NERVOUS SYSTEM SENSITIZATION; CINAHL; CLINICAL TRIAL (TOPIC); HUMAN; HYPERALGESIA; MEDICAL SUBJECT HEADINGS; MEDLINE; NEUROBIOLOGY; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW; ANALGESIA; ANIMAL; BIOLOGICAL MODEL; CROSS-SECTIONAL STUDY; DISEASE MODEL; FACTUAL DATABASE; FORECASTING; MOUSE; NEURALGIA; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; QUESTIONNAIRE; RISK FACTOR; SELF REPORT;

ANEMIA, SICKLE CELL; ANIMALS; CENTRAL NERVOUS SYSTEM SENSITIZATION; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DISEASE MODELS, ANIMAL; FORECASTING; HUMANS; HYPERALGESIA; MICE; MODELS, NEUROLOGICAL; NEURALGIA; PAIN MANAGEMENT; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM; RISK FACTORS; SELF REPORT; SURVEYS AND QUESTIONNAIRES;

EID: 84938209147     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25574     Document Type: Review

References (26)

1. Freynhagen R, Bennett MI. Diagnosis and management of neuropathic pain. BMJ 2009; 339:b3002.
2. Sethna NF, Meier PM, Zurakowski D, Berde CB. Cutaneous sensory abnormalities in children and adolescents with complex regional pain syndromes. Pain 2007; 131:153-161.
3. Treede RD, Meyer RA, Raja SN, Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 1992; 38:397-421.
4. Kohli DR, Li Y, Khasabov SG, Gupta P, Kehl LJ, Ericson ME, Nguyen J, Gupta V, Hebbel RP, Simone DA, Gupta K. Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: Modulation by cannabinoids. Blood 2010; 116:456-465.
5. Vincent L, Vang D, Nguyen J, Gupta M, Luk K, Ericson ME, Simone DA, Gupta K. Mast cell activation contributes to sickle cell pathobiology and pain. Blood 2013; 122:1853-1862.
6. Hillery CA, Kerstein PC, Vilceanu D, Barabas ME, Retherford D, Brandow AM, Wandersee NJ, Stucky CL. Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease. Blood 2011; 118:3376-3383.
7. Garrison SR, Kramer AA, Gerges NZ, Hillery CA, Stucky CL. Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors. Mol Pain 2012; 8:62.
8. Zappia KJ, Garrison SR, Hillery CA, Stucky CL. Cold hypersensitivity increases with age in mice with sickle cell disease. Pain 2014; 155:2476-2485.
9. Kenyon N, Wang L, Spornick N, Khaibullina A, Almeida LE, Cheng Y, Wang J, Guptill V, Finkel JC, Quezado ZM. Sickle cell disease in mice is associated with sensitization of sensory nerve fibers. Exp Biol Med (Maywood) 2015; 240:87-98.
10. Jensen MP. Review of measures of neuropathic pain. Curr Pain Headache Rep 2006; 10:159-166.
11. Wilkie DJ, Molokie R, Boyd-Seal D, Suarez ML, Kim YO, Zong S, Wittert H, Zhao Z, Saunthararajah Y, Wang ZJ. Patient-reported outcomes: Descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. J Natl Med Assoc 2010; 102:18-27.
12. Brandow AM, Farley R, Panepinto JA. Neuropathic pain in patients with sickle cell disease. Pediatr Blood Cancer 2014; 61:512-517.
13. Ezenwa MO, Molokie RE, Wang ZJ, Yao Y, Suarez ML, Pullum C, Schlaeger JM, Fillingim RB, Wilkie DJ. Safety and utility of quantitative sensory testing among adults with sickle cell disease: Indicators of neuropathic pain? Pain Pract 2015;[Epub ahead of print].
14. Brandow AM, Stucky CL, Hillery CA, Hoffmann RG, Panepinto JA. Patients with sickle cell disease have increased sensitivity to cold and heat. Am J Hematol 2013; 88:37-43.
15. O'Leary JD, Crawford MW, Odame I, Shorten GD, McGrath PA. Thermal pain and sensory processing in children with sickle cell disease. Clin J Pain 2014; 30:244-250.
16. Jacob E, Chan VW, Hodge C, Zeltzer L, Zurakowski D, Sethna NF. Sensory and thermal quantitative testing in children with sickle cell disease. J Pediatr Hematol Oncol 2014;[Epub ahead of print].
17. Hollins M, Stonerock GL, Kisaalita NR, Jones S, Orringer E, Gil KM. Detecting the emergence of chronic pain in sickle cell disease. J Pain Symptom Manage 2012; 43:1082-1093.
18. Brandow AM, Farley RA, Dasgupta M, Hoffmann RG, Panepinto JA. The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay. J Pediatr Hematol Oncol 2015; 37:10-15.
19. Molokie RE, Wilkie DJ, Wittert H, Suarez ML, Yao Y, Zhao Z, He Y, Wang ZJ. Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease. Eur J Pharmacol 2014; 723:419-424.
20. Chen Y, Luo F, Yang C, Kirkmire CM, Wang ZJ. Acute inhibition of Ca2+/calmodulin-dependent protein kinase II reverses experimental neuropathic pain in mice. J Pharmaco Exp Ther 2009; 330:650-659.
21. Chen Y, Yang C, Wang ZJ. Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia. J Neurosci 2010; 30:38-46.
22. Luo F, Yang C, Chen Y, Shukla P, Tang L, Wang LX, Wang ZJ. Reversal of chronic inflammatory pain by acute inhibition of Ca2+/calmodulin-dependent protein kinase II. J Pharmacol Exp Ther 2008; 325:267-275.
23. Pain management in children and young adults with sickle cell disease. ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT01954927?term=sickle+cell+neuropathic+pain&rank=2. Accessed August 22, 2014.
24. Lidocaine 5% plasters (Versatis® 5%) in pediatric neuropathic pains and vasoocclusive sickle cell crisis pains. ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT01314300?term=sickle+cell+neuropathic+pain&rank=1. Accessed August 22, 2014.
25. Vaporized cannabis for chronic pain associated with sickle cell disease (Cannabis-SCD). ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT01771731?term=sickle+cell+and+pain&rank=26. Accessed August 22, 2014.
26. Functional neuroimaging of pain using EEG and fMRI. ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT02212691?term=sickle+cell+and+pain&rank=32. Accessed August 22, 2014. .